Your session is about to expire
← Back to Search
Behavioral Change Techniques for Medication Adherence
Study Summary
This trial is testing whether a behavior change intervention can increase medication adherence among people at risk for cardiovascular disease. The intervention will vary in length from 1-10 weeks, and the minimum effective dose will be the length of intervention associated with 80% of participants having a 20% increase in medication adherence.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I cannot walk or it's unsafe for me to join a walking program.I can use a smartphone.I am under 18 years old.I have taken my statin medication less than 60% of the prescribed days.I am currently taking statin medication.I do not use and am not willing to use Vivo Health for my prescriptions.I often forget or choose not to take my statin medications.I am not taking statin medication.I have a history of cardiovascular disease.I am 18 years old or older.I can walk without any restrictions and have never been told by a doctor that walking more could be harmful.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the 5 Behavioral Change Techniques validated by the FDA?
"The safety of the 5 Behavioral Change Techniques is rated as a 1 due to the limited data collected in this Phase 1 trial, which does not offer substantial evidence for either efficacy or security."
What is the current scope of this investigation in terms of those receiving treatment?
"Affirmative. The information accessible via clinicaltrials.gov reveals that this study is presently looking for suitable applicants, with the investigation having been first made public on July 21st 2022 and most recently modified on September 6th 2022. 42 participants must be recruited from a single site to complete the trial."
Is this medical experiment currently seeking new participants?
"Indeed, clinicaltrials.gov reveals that this trial has been open since July 21st 2022 and is actively recruiting 42 patients from one location. This data was last updated on September 6th of the same year."
Share this study with friends
Copy Link
Messenger